AdaptHealth Corp. (NASDAQ:AHCO) Receives Average Recommendation of “Moderate Buy” from Analysts

Shares of AdaptHealth Corp. (NASDAQ:AHCO) have received a consensus rating of “Moderate Buy” from the seven analysts that are covering the company, Marketbeat reports. Two equities research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12 month target price among brokerages that have covered the stock in the last year is $13.60.

AHCO has been the subject of a number of analyst reports. Canaccord Genuity Group boosted their price target on AdaptHealth from $14.00 to $15.00 and gave the stock a “buy” rating in a research report on Thursday, November 6th. Zacks Research raised shares of AdaptHealth from a “strong sell” rating to a “hold” rating in a report on Thursday, January 1st. Wall Street Zen raised shares of AdaptHealth from a “buy” rating to a “strong-buy” rating in a research note on Saturday, January 17th. Finally, Weiss Ratings raised shares of AdaptHealth from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, January 30th.

AdaptHealth Trading Up 0.7%

Shares of NASDAQ AHCO opened at $10.03 on Friday. The company has a quick ratio of 0.86, a current ratio of 1.08 and a debt-to-equity ratio of 1.09. The stock’s 50 day moving average price is $10.10 and its two-hundred day moving average price is $9.57. AdaptHealth has a 52-week low of $7.11 and a 52-week high of $11.63. The stock has a market capitalization of $1.36 billion, a P/E ratio of 18.24, a PEG ratio of 1.13 and a beta of 1.72.

AdaptHealth (NASDAQ:AHCO) last announced its quarterly earnings results on Tuesday, November 4th. The company reported $0.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.24 by ($0.05). The company had revenue of $820.31 million during the quarter, compared to the consensus estimate of $799.62 million. AdaptHealth had a return on equity of 4.85% and a net margin of 2.53%.The company’s revenue for the quarter was up 1.8% on a year-over-year basis. During the same period last year, the business posted $0.15 EPS. On average, analysts anticipate that AdaptHealth will post 0.88 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, Director David Solomon Williams III sold 5,000 shares of the firm’s stock in a transaction on Thursday, December 4th. The stock was sold at an average price of $9.43, for a total transaction of $47,150.00. Following the completion of the sale, the director directly owned 45,045 shares of the company’s stock, valued at $424,774.35. This trade represents a 9.99% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 1.55% of the stock is currently owned by corporate insiders.

Institutional Trading of AdaptHealth

Hedge funds and other institutional investors have recently modified their holdings of the company. Vanguard Group Inc. grew its stake in AdaptHealth by 4.4% in the fourth quarter. Vanguard Group Inc. now owns 11,768,599 shares of the company’s stock valued at $117,215,000 after purchasing an additional 491,106 shares in the last quarter. Deerfield Management Company L.P. grew its stake in shares of AdaptHealth by 15.9% in the 3rd quarter. Deerfield Management Company L.P. now owns 11,477,730 shares of the company’s stock valued at $102,726,000 after buying an additional 1,572,835 shares in the last quarter. Dimensional Fund Advisors LP increased its holdings in AdaptHealth by 15.6% in the third quarter. Dimensional Fund Advisors LP now owns 5,982,070 shares of the company’s stock worth $53,537,000 after buying an additional 809,459 shares during the last quarter. Kennedy Capital Management LLC raised its position in AdaptHealth by 48.8% during the third quarter. Kennedy Capital Management LLC now owns 2,090,138 shares of the company’s stock valued at $18,707,000 after acquiring an additional 685,554 shares in the last quarter. Finally, Invesco Ltd. lifted its stake in AdaptHealth by 50.0% in the second quarter. Invesco Ltd. now owns 1,906,074 shares of the company’s stock valued at $17,974,000 after acquiring an additional 634,973 shares during the last quarter. 82.67% of the stock is currently owned by hedge funds and other institutional investors.

AdaptHealth Company Profile

AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.

The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.